Company intelligence / Profile preview

Protein Therapeutics

Lebanon, New Hampshire, United States

Ownership: Private
Development stage: Other

Overview

Protein Therapeutics was a biotechnology company focused on developing innovative protein-based therapies for inflammatory and autoimmune diseases. The company's core technology centered on enhancing the stability and delivery of therapeutic proteins to improve their efficacy and reduce side effects. Their research primarily targeted cytokine-mediated pathways, including the development of novel inhibitors for interleukin-1 and tumor necrosis factor. Although the company made strides in pre-clinical development, it is no longer actively operating as an independent entity.

Therapeutic areas: OncologyImmunology
Modalities: ProteinRecombinant proteinPeptides
Industry: Biotech

Beyond the preview

Go deeper on Protein Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein Therapeutics.

Explore the full profile